Kynam Capital Management, LP Allakos Inc. Transaction History
Kynam Capital Management, LP
- $1.19 Billion
- Q1 2025
A detailed history of Kynam Capital Management, LP transactions in Allakos Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 74,500 shares of ALLK stock, worth $24,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,500Holding current value
$24,585% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALLK
# of Institutions
67Shares Held
61.7MCall Options Held
71.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA16.6MShares$5.46 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.69MShares$2.87 Million0.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.23MShares$2.39 Million0.06% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$2.03 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$1.13 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...